Novavax expects FDA clearance for Covid vaccine as early as May, CEO says
March 01, 2021 at 17:05 PM EST
The Food and Drug Administration could authorize Novavax's Covid-19 for emergency use as early as May, the company's CEO, Stanley Erck, told CNBC.
